APA (7th ed.) Citation

Huizinga, T., Choy, E., Praestgaard, A., van Hoogstraten, H., LaFontaine, P. R., Guyot, P., . . . Fleischmann, R. (2023). Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison. Rheumatology & Therapy, 10(3), 539. https://doi.org/10.1007/s40744-022-00521-1

Chicago Style (17th ed.) Citation

Huizinga, Thomas, et al. "Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison." Rheumatology & Therapy 10, no. 3 (2023): 539. https://doi.org/10.1007/s40744-022-00521-1.

MLA (9th ed.) Citation

Huizinga, Thomas, et al. "Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison." Rheumatology & Therapy, vol. 10, no. 3, 2023, p. 539, https://doi.org/10.1007/s40744-022-00521-1.